Company page

Zymeworks Inc.

Zymeworks Inc. is a public biotechnology company listed under the ticker ZYME, operating in the American market. The company focuses on developing innovative therapeutic solutions for cancer and other diseases. With a market capitalization of approximately $1.78 billion, Zymeworks is committed to advancing its proprietary technology platforms to improve patient outcomes.